2023 annual financial data
Keros Therapeutics 2023 Net margin
Direct answer
Net margin was -101,319.21%.
Operating income was -169,941,000 USD and net income was -152,992,000 USD.
Operating cash flow was -124,508,000 USD.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 151,000 USD
- Operating income
- -169,941,000 USD
- Net income
- -152,992,000 USD
- Operating cash flow
- -124,508,000 USD